Learn About Neurotrophic Keratitis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Duke Eye Center Of Winston-Salem
Terry Semchyshyn is an Ophthalmologist in Winston-salem, North Carolina. Dr. Semchyshyn is rated as an Advanced provider by MediFind in the treatment of Neurotrophic Keratitis. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Corneal Dystrophy and Perceptive Deafness, and Cataract. Dr. Semchyshyn is currently accepting new patients.
Alessandro Lambiase practices in Rome, Italy. Mr. Lambiase is rated as an Elite expert by MediFind in the treatment of Neurotrophic Keratitis. His top areas of expertise are Neurotrophic Keratitis, Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Vitrectomy, and Corneal Transplant.
Marta Sacchetti practices in Rome, Italy. Ms. Sacchetti is rated as an Elite expert by MediFind in the treatment of Neurotrophic Keratitis. Her top areas of expertise are Neurotrophic Keratitis, Allergic Conjunctivitis, Giant Papillary Conjunctivitis, Corneal Transplant, and Awake Craniotomy.
Summary: The Investigators hypothesize that the recalcitrant nature of ocular GVHD may be related to corneal nerve damage and corneal hypoesthesia. The investigators aim to study the prevalence of corneal hypoesthesia in GVHD patients and its correlation with ocular surface changes.
Summary: This is a Phase II, double-blind, placebo-controlled study to evaluate the safety and efficacy of STSP-0902 ophthalmic solution in patients with neurotrophic keratitis (NK). The study plans to enroll 48 patients with Mackie Stage 2 or 3 NK affecting one or both eyes. Eligible subjects will be randomized 1:1:1 into three dosing groups. Each dosing group will follow a drug-placebo allocation (12 act...